Transcription factor fusions in acute leukemia: variations on a theme

[1]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[2]  B. Porse,et al.  E2F Repression by C/EBPα Is Required for Adipogenesis and Granulopoiesis In Vivo , 2001, Cell.

[3]  James R. Downing,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain , 2001, Molecular and Cellular Biology.

[4]  S. Soignet,et al.  United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Minucci,et al.  Common themes in the pathogenesis of acute myeloid leukemia , 2001, Oncogene.

[6]  I. Weissman,et al.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Tenen,et al.  Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation , 2001, Molecular and Cellular Biology.

[8]  C. Lavau,et al.  The Elongation Domain of ELL Is Dispensable but Its ELL-Associated Factor 1 Interaction Domain Is Essential for MLL-ELL-Induced Leukemogenesis , 2001, Molecular and Cellular Biology.

[9]  F. Calabi,et al.  Gene Targeting Reveals a Crucial Role forMTG8 in the Gut , 2001, Molecular and Cellular Biology.

[10]  S. Hiebert,et al.  TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3 , 2001, Oncogene.

[11]  M. Gobbi,et al.  The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia – analysis of 848 patients , 2001, Leukemia.

[12]  T. Golub,et al.  c-Myc Is a Critical Target for C/EBPα in Granulopoiesis , 2001, Molecular and Cellular Biology.

[13]  M. Ratajczak,et al.  Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. , 2001, Blood.

[14]  M. Diaz,et al.  Protein Interactions of the MLL PHD Fingers Modulate MLL Target Gene Regulation in Human Cells , 2001, Molecular and Cellular Biology.

[15]  Torsten Haferlach,et al.  AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia , 2001, Nature Medicine.

[16]  P. Pandolfi.  Oncogenes and tumor suppressors in the molecular pathogenesis of acute promyelocytic leukemia. , 2001, Human molecular genetics.

[17]  M. Grez,et al.  Multiple Regions of ETO Cooperate in Transcriptional Repression* , 2001, The Journal of Biological Chemistry.

[18]  C. Bloomfield,et al.  Clinical importance of cytogenetics in acute myeloid leukaemia. , 2001, Best practice & research. Clinical haematology.

[19]  Pu Zhang,et al.  Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia , 2001, Nature Genetics.

[20]  J. Rowe,et al.  Biology and therapy of secondary leukaemias. , 2001, Best practice & research. Clinical haematology.

[21]  P. Pandolfi,et al.  Role of Promyelocytic Leukemia (Pml) Protein in Tumor Suppression , 2001, The Journal of experimental medicine.

[22]  U. Thorsteinsdóttir,et al.  NUP98–HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice , 2001, The EMBO journal.

[23]  E. Wagner,et al.  Chronic Myeloid Leukemia with Increased Granulocyte Progenitors in Mice Lacking JunB Expression in the Myeloid Lineage , 2001, Cell.

[24]  S. Stifani,et al.  Association with the Nuclear Matrix and Interaction with Groucho and RUNX Proteins Regulate the Transcription Repression Activity of the Basic Helix Loop Helix Factor Hes1* , 2001, The Journal of Biological Chemistry.

[25]  Shigeru Chiba,et al.  Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis , 2001, Oncogene.

[26]  Unnur Thorsteinsdottir,et al.  Defining Roles for HOX and MEIS1 Genes in Induction of Acute Myeloid Leukemia , 2001, Molecular and Cellular Biology.

[27]  A. Jakubowiak,et al.  Inhibition of the Transforming Growth Factor β1 Signaling Pathway by the AML1/ETO Leukemia-associated Fusion Protein* , 2000, The Journal of Biological Chemistry.

[28]  J. Licht,et al.  AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein. , 2000, Blood.

[29]  H. Koeffler,et al.  The aberrant fusion proteins PML-RARα and PLZF-RARα contribute to the overexpression of cyclin A1 in acute promyelocytic leukemia , 2000 .

[30]  R. Sood,et al.  Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Slovak,et al.  t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF). , 2000, Cancer research.

[32]  A Zelent,et al.  Two critical hits for promyelocytic leukemia. , 2000, Molecular cell.

[33]  J. Massagué,et al.  TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders , 2000, Cell.

[34]  Ailan Guo,et al.  The function of PML in p53-dependent apoptosis , 2000, Nature Cell Biology.

[35]  G. Stein,et al.  Leukemia‐associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies , 2000, Journal of cellular biochemistry.

[36]  D. Tenen,et al.  Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model. , 2000, Blood.

[37]  P. Pandolfi,et al.  Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Peschle,et al.  PML/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype. , 2000, Blood.

[39]  E. Simpson,et al.  Inter‐chromosomal recombination of Mll and Af9 genes mediated by cre‐loxP in mouse development , 2000, EMBO reports.

[40]  D. T. Kurtz,et al.  C/EBPα Inhibits Cell Growth via Direct Repression of E2F-DP-Mediated Transcription , 2000, Molecular and Cellular Biology.

[41]  Y. Odaka,et al.  Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8) , 2000, Oncogene.

[42]  S. Nakamura,et al.  Analysis of genes under the downstream control of the t(8;21) fusion protein AML1-MTG8: overexpression of the TIS11b (ERF-1, cMG1) gene induces myeloid cell proliferation in response to G-CSF. , 2000, Blood.

[43]  N. Fortunel,et al.  p21cip1 mRNA is controlled by endogenous transforming growth factor‐β1 in quiescent human hematopoietic stem/progenitor cells , 2000 .

[44]  I. Weissman,et al.  AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  R. Derynck,et al.  Transcriptional Regulation of the Transforming Growth Factor-β-inducible Mouse Germ Line Ig α Constant Region Gene by Functional Cooperation of Smad, CREB, and AML Family Members* , 2000, The Journal of Biological Chemistry.

[46]  Donoghue,et al.  RTK mutations and human syndromes: when good receptors turn bad , 2000, Trends in genetics : TIG.

[47]  P. Pandolfi,et al.  Plzf regulates limb and axial skeletal patterning , 2000, Nature Genetics.

[48]  A. Friedman,et al.  Exogenous cdk4 overcomes reducedcdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteins , 2000, Oncogene.

[49]  S. Rutella,et al.  Modulation of bcl-2 and p27 in human primitive proliferating hematopoietic progenitors by autocrine TGF-beta1 is a cell cycle-independent effect and influences their hematopoietic potential. , 2000, Blood.

[50]  S. Minucci,et al.  Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation. , 2000, Molecular cell.

[51]  Pier Paolo Pandolfi,et al.  The transcriptional role of PML and the nuclear body , 2000, Nature Cell Biology.

[52]  R. Evans,et al.  Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers. , 2000, Molecular cell.

[53]  P. Pandolfi,et al.  Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.

[54]  J. Rowley,et al.  Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[55]  L. Attisano,et al.  Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Löwenberg,et al.  Biological characteristics and prognosis of adult acute myeloid leukemia with internal tandem duplications in the Flt3 gene , 2000, Leukemia.

[57]  Tony Kouzarides,et al.  Acetylation: a regulatory modification to rival phosphorylation? , 2000, The EMBO journal.

[58]  J. Licht,et al.  The ETO Protein Disrupted in t(8;21)-Associated Acute Myeloid Leukemia Is a Corepressor for the Promyelocytic Leukemia Zinc Finger Protein , 2000, Molecular and Cellular Biology.

[59]  P. Pandolfi,et al.  Promyelocytic Leukemia Protein (Pml) and Daxx Participate in a Novel Nuclear Pathway for Apoptosis , 2000, The Journal of experimental medicine.

[60]  G. Nucifora,et al.  Human AML1/MDS1/EVI1 fusion protein induces an acute myelogenous leukemia (AML) in mice: a model for human AML. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[61]  T. Grundström,et al.  Smad and AML Proteins Synergistically Confer Transforming Growth Factor β1 Responsiveness to Human Germ-line IgA Genes* , 2000, The Journal of Biological Chemistry.

[62]  James R. Downing,et al.  Expression of the AML-1 Oncogene Shortens the G1Phase of the Cell Cycle* , 2000, The Journal of Biological Chemistry.

[63]  O. Rozenblatt-Rosen,et al.  Self-association of the SET domains of human ALL-1 and of Drosophila TRITHORAX and ASH1 proteins , 2000, Oncogene.

[64]  P. Peterlongo,et al.  C-kit mutations in core binding factor leukemias. , 2000, Blood.

[65]  E. Seto,et al.  A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia* , 2000, The Journal of Biological Chemistry.

[66]  G. Karsenty,et al.  The Mammalian Basic Helix Loop Helix Protein HES-1 Binds to and Modulates the Transactivating Function of the Runt-related Factor Cbfa1* , 2000, The Journal of Biological Chemistry.

[67]  G. Stein,et al.  The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFα2 transcription factor , 1999 .

[68]  K. Miyazono,et al.  c-Ski Acts as a Transcriptional Co-repressor in Transforming Growth Factor-β Signaling through Interaction with Smads* , 1999, The Journal of Biological Chemistry.

[69]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[70]  G. Nucifora,et al.  The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. , 1999, Biochemical and biophysical research communications.

[71]  C. Felix,et al.  The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion. , 1999, Blood.

[72]  Y. Arai,et al.  11p15 translocations involving the NUP98 gene in childhood therapy‐related acute myeloid leukemia/myelodysplastic syndrome , 1999, Genes, chromosomes & cancer.

[73]  K. Miyazono,et al.  Interaction and Functional Cooperation of PEBP2/CBF with Smads , 1999, The Journal of Biological Chemistry.

[74]  S. Hiebert,et al.  The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[75]  R. Weinberg,et al.  SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[76]  K. Luo,et al.  Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein , 1999 .

[77]  Lisa Garrett,et al.  The fusion gene Cbfb-MYH11 blocks myeloid differentiation and predisposes mice to acute myelomonocytic leukaemia , 1999, Nature Genetics.

[78]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[79]  R. Weinberg,et al.  Interaction of the Ski Oncoprotein with Smad3 Regulates TGF-β Signaling , 1999 .

[80]  A. Fornace,et al.  Leukemic HRX Fusion Proteins Inhibit GADD34-Induced Apoptosis and Associate with the GADD34 and hSNF5/INI1 Proteins , 1999, Molecular and Cellular Biology.

[81]  J. Downing,et al.  Both TEL and AML-1 Contribute Repression Domains to the t(12;21) Fusion Protein , 1999, Molecular and Cellular Biology.

[82]  P. Pandolfi,et al.  In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications , 1999, Oncogene.

[83]  S. Choe,et al.  AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene. , 1999, The international journal of biochemistry & cell biology.

[84]  Qiang Zhou,et al.  The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling. , 1999, Genes & development.

[85]  R. Berger,et al.  The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. , 1999, Human molecular genetics.

[86]  H. Snoeck,et al.  Developmentally regulated responsiveness to transforming growth factor-β is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells , 1999, Leukemia.

[87]  T Nakamura,et al.  NUP98 is fused to PMX1 homeobox gene in human acute myelogenous leukemia with chromosome translocation t(1;11)(q23;p15). , 1999, Blood.

[88]  Yoshiaki Ito,et al.  Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2 , 1999, Oncogene.

[89]  M. Seto,et al.  Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants , 1999, Leukemia.

[90]  T. Aso,et al.  Physical Interaction and Functional Antagonism between the RNA Polymerase II Elongation Factor ELL and p53* , 1999, The Journal of Biological Chemistry.

[91]  Jia Liu,et al.  Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[92]  Jonathan D. Licht,et al.  Deconstructing a Disease: RAR, Its Fusion Partners, and Their Roles in the Pathogenesis of Acute Promyelocytic Leukemia , 1999 .

[93]  Lin-Feng Chen,et al.  A WW domain‐containing Yes‐associated protein (YAP) is a novel transcriptional co‐activator , 1999, The EMBO journal.

[94]  S. Nimer,et al.  Functional and Physical Interactions between AML1 Proteins and an ETS Protein, MEF: Implications for the Pathogenesis of t(8;21)-Positive Leukemias , 1999, Molecular and Cellular Biology.

[95]  N. Mahmud,et al.  Possible involvement of bcl‐2 in regulation of cell‐cycle progression of haemopoietic cells by transforming growth factor‐β1 , 1999, British journal of haematology.

[96]  J. Massagué,et al.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. , 1999, Genes & development.

[97]  A. Iwama,et al.  A Novel Ubiquitin-Specific Protease, UBP43, Cloned from Leukemia Fusion Protein AML1-ETO-Expressing Mice, Functions in Hematopoietic Cell Differentiation , 1999, Molecular and Cellular Biology.

[98]  B. Fontoura,et al.  A Conserved Biogenesis Pathway for Nucleoporins: Proteolytic Processing of a 186-Kilodalton Precursor Generates Nup98 and the Novel Nucleoporin, Nup96 , 1999, The Journal of cell biology.

[99]  T. Graf,et al.  Mutual activation of Ets‐1 and AML1 DNA binding by direct interaction of their autoinhibitory domains , 1999, The EMBO journal.

[100]  A. Jakubowiak,et al.  The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1 , 1999, Oncogene.

[101]  N. Kamada,et al.  Low BCL-2 expression in acute leukemia with t(8;21) chromosomal abnormality , 1999, Leukemia.

[102]  S. Kaul,et al.  Viral Ski Inhibits Retinoblastoma Protein (Rb)-mediated Transcriptional Repression in a Dominant Negative Fashion* , 1999, The Journal of Biological Chemistry.

[103]  S. Ishii,et al.  Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. , 1999, Genes & development.

[104]  T. Grundström,et al.  AML and Ets proteins regulate the Iα1 germ‐line promoter , 1999, European journal of immunology.

[105]  J. Downing,et al.  Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter , 1999, Oncogene.

[106]  M. Cleary,et al.  CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity , 1999, Molecular and Cellular Biology.

[107]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[108]  C. Glass,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.

[109]  J. Radich,et al.  The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[110]  N. Speck,et al.  The Leukemic Protein Core Binding Factor β (CBFβ)–Smooth-Muscle Myosin Heavy Chain Sequesters CBFα2 into Cytoskeletal Filaments and Aggregates , 1998, Molecular and Cellular Biology.

[111]  K. Tanaka,et al.  TLE, the human homolog of groucho, interacts with AML1 and acts as a repressor of AML1-induced transactivation. , 1998, Biochemical and biophysical research communications.

[112]  A. Friedman,et al.  The Core Binding Factor (CBF) α Interaction Domain and the Smooth Muscle Myosin Heavy Chain (SMMHC) Segment of CBFβ-SMMHC Are Both Required to Slow Cell Proliferation* , 1998, The Journal of Biological Chemistry.

[113]  P. Pandolfi,et al.  Pml is essential for multiple apoptotic pathways , 1998, Nature Genetics.

[114]  N. Taylor,et al.  Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[115]  D. Landsman,et al.  AT-hook motifs identified in a wide variety of DNA-binding proteins. , 1998, Nucleic acids research.

[116]  T. Shows,et al.  NUP98-HOXD13 gene fusion in therapy-related acute myelogenous leukemia. , 1998, Cancer research.

[117]  I. Weissman,et al.  The PEBP2betaMYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[118]  H. Beug,et al.  Transformation of hematopoietic cells by the Ski oncoprotein involves repression of retinoic acid receptor signaling. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[119]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[120]  J. Licht,et al.  The Promyelocytic Leukemia Zinc Finger Protein Affects Myeloid Cell Growth, Differentiation, and Apoptosis , 1998, Molecular and Cellular Biology.

[121]  Y Fujiwara,et al.  The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow. , 1998, Genes & development.

[122]  J. Massagué,et al.  Determinants of specificity in TGF-beta signal transduction. , 1998, Genes & development.

[123]  S. Tsai,et al.  The ets Family Member Tel Binds to the Fli-1 Oncoprotein and Inhibits Its Transcriptional Activity* , 1998, The Journal of Biological Chemistry.

[124]  K. Irie,et al.  The oncoprotein Evi-1 represses TGF-β signalling by inhibiting Smad3 , 1998, Nature.

[125]  D. Tenen,et al.  CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.

[126]  Unnur Thorsteinsdottir,et al.  Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b , 1998, The EMBO journal.

[127]  D. Tenen,et al.  Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 , 1998, Molecular and Cellular Biology.

[128]  Y. Kanno,et al.  Cytoplasmic Sequestration of the Polyomavirus Enhancer Binding Protein 2 (PEBP2)/Core Binding Factor α (CBFα) Subunit by the Leukemia-Related PEBP2/CBFβ-SMMHC Fusion Protein Inhibits PEBP2/CBF-Mediated Transactivation , 1998, Molecular and Cellular Biology.

[129]  J. Schuetz,et al.  The MYND Motif Is Required for Repression of Basal Transcription from the Multidrug Resistance 1 Promoter by the t(8;21) Fusion Protein , 1998, Molecular and Cellular Biology.

[130]  S. Chevret,et al.  RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up , 1998, Leukemia.

[131]  M. Ohki,et al.  Interaction and functional cooperation of the leukemia‐associated factors AML1 and p300 in myeloid cell differentiation , 1998, The EMBO journal.

[132]  J. Downing,et al.  Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. , 1998, Blood.

[133]  O. Rozenblatt-Rosen,et al.  The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[134]  M. Hung,et al.  Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis , 1998, Oncogene.

[135]  P. Nowell,et al.  Potential role for wild-type p53 in leukemias with MLL gene translocations , 1998, Oncogene.

[136]  S. Minucci,et al.  Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia , 1998, Nature.

[137]  S. Inoue,et al.  Role of the histone deacetylase complex in acute promyelocytic leukaemia , 1998, Nature.

[138]  J. Lawrence,et al.  Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[139]  Y. Ito,et al.  Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[140]  C. Tribioli,et al.  Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL , 1998, Nature Genetics.

[141]  N. Nomura,et al.  The AML1-MTG8 Leukemic Fusion Protein Forms a Complex with a Novel Member of the MTG8(ETO/CDR) Family, MTGR1 , 1998, Molecular and Cellular Biology.

[142]  J. Downing,et al.  The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation , 1998, Molecular and Cellular Biology.

[143]  Michael L. Cleary,et al.  The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX , 1998, Molecular and Cellular Biology.

[144]  M. Greaves,et al.  Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[145]  D C Linch,et al.  Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials , 1997, British journal of haematology.

[146]  A T Look,et al.  Oncogenic transcription factors in the human acute leukemias. , 1997, Science.

[147]  I. Dybedal,et al.  Transforming Growth Factor-β1 Abrogates Fas-Induced Growth Suppression and Apoptosis of Murine Bone Marrow Progenitor Cells , 1997 .

[148]  X. Le,et al.  Stable overexpression of PML alters regulation of cell cycle progression in HeLa cells. , 1997, Carcinogenesis.

[149]  M. Pearson,et al.  Cell death induction by the acute promyelocytic leukemia-specific PML/RARalpha fusion protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[150]  M. Grunstein.  Histone acetylation in chromatin structure and transcription , 1997, Nature.

[151]  Alfred L. Fisher,et al.  Groucho-dependent and -independent repression activities of Runt domain proteins , 1997, Molecular and cellular biology.

[152]  A. Friedman,et al.  Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb , 1997, Molecular and cellular biology.

[153]  M. Taniwaki,et al.  Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia , 1997, Leukemia.

[154]  C. Bloomfield,et al.  Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22). , 1997, Blood.

[155]  D. Gilliland,et al.  TEL is one of the targets for deletion on 12p in many cases of childhood B-lineage acute lymphoblastic leukemia , 1997, Leukemia.

[156]  C. Peschle,et al.  Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling , 1997, Molecular and cellular biology.

[157]  R. Bleackley,et al.  Mutational Analysis of the Murine Granzyme B Gene Promoter in Primary T Cells and a T Cell Clone* , 1997, The Journal of Biological Chemistry.

[158]  M. Cleary,et al.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX–ENL , 1997, The EMBO journal.

[159]  T. Golub,et al.  Yolk sac angiogenic defect and intra‐embryonic apoptosis in mice lacking the Ets‐related factor TEL , 1997, The EMBO journal.

[160]  C. Dang,et al.  Nuclear punctate distribution of ALL-1 is conferred by distinct elements at the N terminus of the protein. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[161]  Scott A. Peterson,et al.  Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.

[162]  J. Lawrence,et al.  Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[163]  F. Hosoda,et al.  The inv(11)(p15q22) chromosome translocation of de novo and therapy-related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. , 1997, Blood.

[164]  G. Rodan,et al.  The Missing Bone , 1997, Cell.

[165]  C. Tribioli,et al.  Acute leukemia with promyelocytic features in PML/RARα transgenic mice , 1997 .

[166]  G. Blobel,et al.  Cloning and characterization of human karyopherin β3 , 1997 .

[167]  I. Weissman,et al.  A PMLRARα transgene initiates murine acute promyelocytic leukemia , 1997 .

[168]  J. Rowley,et al.  Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[169]  M. Marín‐Padilla,et al.  Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene , 1997, Nature Genetics.

[170]  R Grosschedl,et al.  ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function. , 1997, Genes & development.

[171]  S. Langabeer,et al.  Frequency of CBFβ/MYH11 fusion transcripts in patients entered into the U.K. MRC AML trials , 1997 .

[172]  C. Croce,et al.  The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its eps15 translocation partner. , 1997, Cancer research.

[173]  D. Tenen,et al.  Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[174]  T. Ley,et al.  Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. , 1997, Blood.

[175]  A. Iavarone,et al.  Transcriptional Activation of the Human p21WAF1/CIP1 Gene by Retinoic Acid Receptor , 1996, The Journal of Biological Chemistry.

[176]  H P Koeffler,et al.  TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. , 1996, Blood.

[177]  J. Zhang,et al.  The AML1/ETO fusion protein activates transcription of BCL-2. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[178]  C. Wijmenga,et al.  Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.

[179]  F. Alt,et al.  The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In Vivo , 1996, Cell.

[180]  J. Potter,et al.  Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group , 1996, Cancer Causes & Control.

[181]  F. Ruscetti,et al.  Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[182]  J. Rowley,et al.  Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[183]  E. Dmitrovsky,et al.  Transgenic expression of PML/RARalpha impairs myelopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[184]  P. Chambon.  A decade of molecular biology of retinoic acid receptors , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[185]  C. Wijmenga,et al.  Identification of the chimeric protein product of the CBFB‐MYH11 fusion gene in inv(16) leukemia cells , 1996 .

[186]  M. Marín‐Padilla,et al.  Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[187]  J. Licht,et al.  Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[188]  C. Croce,et al.  Complete exon structure of the ALL1 gene. , 1996, Cancer research.

[189]  T. Golub,et al.  The t(12;21) translocation converts AML-1B from an activator to a repressor of transcription , 1996, Molecular and cellular biology.

[190]  D. Tenen,et al.  CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter , 1996, Molecular and cellular biology.

[191]  E. Macintyre,et al.  Molecular detection of t(8;21)/AML1‐ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype , 1996, British journal of haematology.

[192]  Keisuke Toyama,et al.  The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP96 and class I homeoprotein HOXA9 , 1996, Nature Genetics.

[193]  S. Corey,et al.  The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. , 1996, Blood.

[194]  A. Feinberg,et al.  Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia , 1996, Nature Genetics.

[195]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[196]  C. Croce,et al.  Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[197]  P. Quesenberry,et al.  The ski/sno protooncogene family in hematopoietic development. , 1995, Blood.

[198]  James M. Roberts,et al.  TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. , 1995, Blood.

[199]  M. Fornerod,et al.  Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[200]  K. Arai,et al.  Positive and negative regulation of granulocyte-macrophage colony-stimulating factor promoter activity by AML1-related transcription factor, PEBP2. , 1995, Blood.

[201]  D C Ward,et al.  Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[202]  G. Blobel,et al.  The peptide repeat domain of nucleoporin Nup98 functions as a docking site in transport across the nuclear pore complex , 1995, Cell.

[203]  R Grosschedl,et al.  Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions. , 1995, Genes & development.

[204]  B. Kwabi-Addo,et al.  A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination , 1995, Nature Genetics.

[205]  F. Collins,et al.  The leukemic core binding factor beta-smooth muscle myosin heavy chain (CBF beta-SMMHC) chimeric protein requires both CBF beta and myosin heavy chain domains for transformation of NIH 3T3 cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[206]  Y. Ito,et al.  Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF , 1995, Molecular and cellular biology.

[207]  A. Zelenetz,et al.  Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17). , 1995, Blood.

[208]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[209]  J. Rowley,et al.  11q23 translocations split the "AT-hook" cruciform DNA-binding region and the transcriptional repression domain from the activation domain of the mixed-lineage leukemia (MLL) gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[210]  S Meyers,et al.  PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells , 1994, Molecular and cellular biology.

[211]  F. Ruscetti,et al.  Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. , 1994, Blood.

[212]  J. Byrd,et al.  Recurrent granulocytic sarcoma. An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule , 1994, Cancer.

[213]  H. Drabkin,et al.  The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. , 1994, Cancer research.

[214]  N. Stuurman,et al.  The t(15;17) translocation alters a nuclear body in a retinoic acid‐reversible fashion. , 1994, The EMBO journal.

[215]  S. Nimer,et al.  Characterization of a cell-type-restricted negative regulatory activity of the human granulocyte-macrophage colony-stimulating factor gene , 1994, Molecular and cellular biology.

[216]  G. Blobel,et al.  The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[217]  R. Evans,et al.  A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein , 1994, Cell.

[218]  Maria Carmo-Fonseca,et al.  Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.

[219]  N. Speck,et al.  Cooperative binding of Ets-1 and core binding factor to DNA , 1994, Molecular and cellular biology.

[220]  P. Pelicci,et al.  Frequency of RAS and p53 mutations in acute promyelocytic leukemias. , 1993, Leukemia & lymphoma.

[221]  J. Downing,et al.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions , 1993, Molecular and cellular biology.

[222]  J. Rowley,et al.  Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. , 1993, The New England journal of medicine.

[223]  F. Collins,et al.  Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia. , 1993, Science.

[224]  Myriam Alcalay,et al.  The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells , 1993, Cell.

[225]  C. Croce,et al.  Analysis of the murine All-1 gene reveals conserved domains with human ALL-1 and identifies a motif shared with DNA methyltransferases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[226]  M. Ohki,et al.  The t(8;21) translocation in acute myeloid leukemia results in production of an AML1‐MTG8 fusion transcript. , 1993, The EMBO journal.

[227]  A. Zelent,et al.  Fusion between a novel Krüppel‐like zinc finger gene and the retinoic acid receptor‐alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. , 1993, The EMBO journal.

[228]  J. Redondo,et al.  Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. , 1992, Molecular and cellular biology.

[229]  H. Prosser,et al.  A phorbol ester response element within the human T-cell receptor beta-chain enhancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[230]  P. Harte,et al.  Molecular characterization of the trithorax gene, a positive regulator of homeotic gene expression in Drosophila , 1991, Mechanisms of Development.

[231]  C. Peschle,et al.  Pure Human Hematopoietic Progenitors: Direct Inhibitory Effect of Transforming Growth Factors‐β1 and ‐β2 , 1991 .

[232]  S. Jacobsen,et al.  Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. , 1991, Blood.

[233]  R Berger,et al.  All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. , 1990, Blood.

[234]  P. Ganly,et al.  Infant acute lymphoblastic leukaemia with t(11;19) , 1990, British journal of haematology.

[235]  R. Larson,et al.  Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. , 1986, Blood.

[236]  G Flandrin,et al.  Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. , 1985, Annals of internal medicine.

[237]  M. Temple,et al.  ACUTE MYELOBLASTIC LEUKAEMIA AND t(8;21) TRANSLOCATION , 1984, British journal of haematology.

[238]  D. Swirsky,et al.  8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features , 1984, British journal of haematology.

[239]  R. Larson,et al.  Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association. , 1983, The New England journal of medicine.

[240]  K. MacKenzie,et al.  The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. , 2002, Blood.

[241]  M. Gerstein,et al.  Genomic and proteomic analysis of the myeloid differentiation program. , 2001, Blood.

[242]  P. Pelicci,et al.  Effects of the acute myeloid leukemia--associated fusion proteins on nuclear architecture. , 2001, Seminars in hematology.

[243]  G. Stein,et al.  Subnuclear organization and trafficking of regulatory proteins: Implications for biological control and cancer , 2000, Journal of cellular biochemistry. Supplement.

[244]  N. Fortunel,et al.  Transforming growth factor-b : pleiotropic role in the regulation of hematopoiesis , 2000 .

[245]  E. Wagner,et al.  [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia]. , 1999, Verhandlungen der Deutschen Gesellschaft fur Pathologie.

[246]  Y. Yazaki,et al.  The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. , 1998, Blood.

[247]  H. Moses,et al.  Signal transduction by transforming growth factor‐β: A cooperative paradigm with extensive negative regulation , 1998, Journal of cellular biochemistry.

[248]  S. Soignet,et al.  All-trans retinoic acid significantly increases 5-year survival in patients with acute promyelocytic leukemia: long-term follow-up of the New York study , 1997, Cancer Chemotherapy and Pharmacology.

[249]  N. Speck,et al.  CBFβ-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells , 1997, Oncogene.

[250]  D. Tenen,et al.  Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. , 1996, Current topics in microbiology and immunology.

[251]  J. Rowley,et al.  The mixed lineage leukemia (MLL) protein involved in 11q23 translocations contains a domain that binds cruciform DNA and scaffold attachment region (SAR) DNA. , 1996, Current Topics in Microbiology and Immunology.

[252]  R. Warrell.  Pathogenesis and management of acute promyelocytic leukemia. , 1996, Annual review of medicine.

[253]  E. Wattel,et al.  MDS and AML with 17p deletion are associated to specific dysgranulopoiesis and a high incidence of p53 mutations , 1994 .

[254]  F. Behm,et al.  Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.